5-Fluoro uracil |
Dynasan 114 and Dynasan 118 |
Prolonged release in simulated colonic media |
Apomorphine |
Glycerylmonostearate, polyethylene glycol monostearate |
Enhanced bioavailability in rats |
Calcitonin |
Trimyristin |
Improvement of the efficacy of proteins |
Clozapine |
Trimyristin, Tristearin and Tripalmitin |
Improvement of bioavailability |
Cyclosporin A |
Glycerylmonostearate and glycerylpalmitostearate. |
Controlled release |
Gonadotropin release hormone |
Monostearin |
Prolonged release |
Ibuprofen |
Stearic acid, Triluarin and Tripalmitin |
Stable formulation with low toxicity |
Idarubicin |
Emulsifying wax |
Delivery of oral proteins |
Insulin |
Stearin acid, octadecyl alcohol, cetylpalmitate, glycerylpalmitostearate, glyceryltripalmitate, glycerylbehenate and glycerylmonostearate. |
Potential for oral delivery of proteins. |
Lopinavir |
Campritol 888 ATO |
Bioavailability enhanced |
Nimusulide |
Glycerylbehanate, palmitostearate, glyceryltristearate |
Sustained release of drug |
Progesterone |
Monostearin, stearic acid and oleic acid |
Potential for oral drug delivery |
Repaglinide |
Glycerylmonostearate and tristearin |
Reduced toxicity |
Tetracycline |
Gycerylmonostearate and stearic acid |
Sustained release |